Metalyse®

Metalyse® (tenecteplase) is indicated for the thrombolytic treatment of acute myocardial infarction (AMI). Metalyse® (tenecteplase) 25mg is indicated in adults for the thrombolytic treatment of acute ischaemic stroke (AIS) within 4.5 hours from last known well and after exclusion of intracranial haemorrhage.¹